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Background: Heart failure is a prevalent health problem associated with costly hospital readmissions. Transitional
care programs have been shown to reduce readmissions but are costly to implement. Evidence regarding the
effectiveness of telemonitoring in managing the care of this chronic condition is mixed. The objective of this
randomized controlled comparative effectiveness study is to evaluate the effectiveness of a care transition
intervention that includes pre-discharge education about heart failure and post-discharge telephone nurse coaching
combined with home telemonitoring of weight, blood pressure, heart rate, and symptoms in reducing all-cause
180-day hospital readmissions for older adults hospitalized with heart failure.
Methods/Design: A multi-center, randomized controlled trial is being conducted at six academic health systems in
California. A total of 1,500 patients aged 50 years and older will be enrolled during a hospitalization for treatment
of heart failure. Patients in the intervention group will receive intensive patient education using the ‘teach-back’
method and receive instruction in using the telemonitoring equipment. Following hospital discharge, they will
receive a series of nine scheduled health coaching telephone calls over 6 months from nurses located in a
centralized call center. The nurses also will call patients and patients’ physicians in response to alerts generated by
the telemonitoring system, based on predetermined parameters. The primary outcome is readmission for any cause
within 180 days. Secondary outcomes include 30-day readmission, mortality, hospital days, emergency department
(ED) visits, hospital cost, and health-related quality of life.
Discussion: BEAT-HF is one of the largest randomized controlled trials of telemonitoring in patients with heart
failure, and the first explicitly to adapt the care transition approach and combine it with remote telemonitoring. The
study population also includes patients with a wide range of demographic and socioeconomic characteristics. Once
completed, the study will be a rich resource of information on how best to use remote technology in the care
management of patients with chronic heart failure.
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Heart failure is a prevalent and costly condition, affecting
some 5.1 million people in the U.S. [1]. It accounts for
more than 1 million hospitalizations and approximately
2.8 million physician office, emergency department (ED),
and hospital outpatient visits each year, at an estimated
cost exceeding $32 billion [2]. Heart failure is the most
common reason for both hospitalization and readmission
among Medicare beneficiaries [3]. The Centers for Medi-
care & Medicaid Services (CMS) has publicly reported
hospital readmission rates for Medicare beneficiaries with
heart failure on its Hospital Compare website since 2009.
The national 30-day heart failure readmission rate for
the period July 2009 to June 2012 was 23.1% [4], with
substantial variation among hospitals [5,6]. Excess 30-day
readmissions for Medicare patients discharged with three
targeted conditions, including heart failure, now trigger
a financial penalty through the Hospital Readmission
Reduction Program (HRRP) mandated by the Patient
Protection and Affordable Care Act [7].
Estimates of the proportion of readmissions that are
potentially avoidable vary widely [8]. However, the fact
that 52% of Medicare patients readmitted within 30 days
of a heart failure discharge had not seen an outpatient
provider [3] has focused attention on patients’ transition
from the hospital - where they are primarily passive recipi-
ents of care - to home, where they must be responsible for
their own care. Interventions to improve the care transi-
tion process have been shown to prevent readmissions
while potentially improving morbidity and mortality in
randomized controlled trials, including the Transitional
Care Program [9,10] and the Care Transition Intervention
[11]. However, these approaches require face-to-face inter-
action with patients in their homes. This makes them
costly and difficult to sustain in the current hospital and
physician reimbursement environment, which remains
predominantly fee-for-service [12]. A less costly but still
effective care transition intervention would assist hospitals
as they strive to redesign their services in anticipation
of different payment models, such as bundled payments
and Accountable Care Organizations, mandated by the
Affordable Care Act.
Many stakeholders are hoping that technology can be
a cost-effective substitute for in-person transition coa-
ches, allowing early intervention to prevent subsequent
healthcare utilization. Some remote telehealth programs
use standard telephones to deliver education and com-
municate patient reports of self-monitoring, while others
use telemonitoring devices that transmit physiologic data
using digital, wireless, or Bluetooth technology. However,
evidence has been mixed regarding the effectiveness of
these programs for patients with heart failure. Inglis et al.’s
2011 Cochrane Review conducted a meta-analysis of stud-
ies using standard telephones (referred to as ‘structuredtelephone support’) or telemonitoring devices for patients
with heart failure, based on study results published from
2006 through 2009. Both approaches were found to be
effective in reducing the risk of heart failure-specific
hospitalizations and all-cause mortality and also showed
a small benefit for all-cause hospitalization [13,14]. Most
of the included studies were relatively small. The meta-
analysis did not include two larger, more recent multi-
center studies, Telemonitoring to Improve Heart Failure
Outcomes (TELE-HF, 1,653 patients) [15] or Telemedical
Interventional Monitoring in Heart Failure (TIM-HF,
710 patients) [16]. The Tele-HF intervention had no
effect on all-cause readmission or death within 180 days,
and no significant effect on secondary endpoints such
as hospitalization for HF, hospital days, or time to the
primary endpoint. Tele-HF used an interactive voice
response system that required the patient to enter daily
weight and symptoms using the touchtone keys on a
standard telephone. This lack of human contact may
have been the reason for Tele-HF’s low adherence rate
of 55% at the end of 6 months. The same investigators
had conducted a small prior study that successfully
reduced readmission rates among patients with heart
failure using a nurse-based telehealth intervention, sug-
gesting that the nurse role [17] and the optimal balance
of human and technological resources [18] are critical.
TIM-HF used wireless technology with a personal digital
assistant, and had 81% adherence over a median of
26 months of follow-up. However, this study also found
no effect on its primary endpoint, total mortality, or on
the composite measure of cardiovascular mortality and
heart failure hospitalization after 1 year [16]. Thus, the
effectiveness of these programs remains unclear, and
additional evidence is needed to understand why some
interventions succeeded while others did not.
This study, Better Effectiveness After Transition - Heart
Failure (BEAT-HF) has several important features. The
intervention combines a telephonic adaptation of care
transition programs with telemonitoring. It will be one of
the largest randomized controlled trials of telemonitoring
in heart failure, with a projected sample size of 1,500
patients. Patients will be enrolled at six sites throughout
the state of California and will include a substantial pro-
portion of racial/ethnic minority subjects and individ-
uals with limited English proficiency. In addition to the
standard outcomes of readmission, mortality, and hos-
pital days, we will collect data to assess health literacy,
depression, social support, informal caregiving, and medi-
cation adherence in addition to health-related quality of
life (HRQOL).
The main objective of the BEAT-HF study is to evaluate
the effectiveness of this remote care transition interven-
tion in reducing all-cause 180-day hospital readmissions
for older adults hospitalized with heart failure. We will
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hospital days, hospital costs, and HRQOL. Secondary
objectives are to understand the influence of moderat-
ing variables such as socioeconomic status, health literacy,
and patient co-morbidities, as well as the impact of the
intervention on intermediate factors such as self-care
knowledge and behavior and medication adherence.
Methods/Design
Design
BEAT-HF is a prospective, two-arm multi-center, random-
ized controlled trial being conducted at six academic
health systems in California to compare usual care with a
telehealth-based care transition intervention for older pa-
tients who are discharged home after inpatient treatment
for decompensated heart failure. We plan to enroll 1,500
patients before hospital discharge, with half randomized
to usual care and half to an education/nurse coaching/
telemonitoring intervention. Randomization is stratified
by medical center. The original BEAT-HF design was a
three arm randomized controlled study comparing an
adaptation of the Tele-HF protocol, telephone-based
health coaching based on the Transitional Care model,
and concurrent controls. However, the findings from
the Tele-HF study led to a redesign, in which we de-
cided to combine the care transition telephone coaching
with telemonitoring.
The study has been approved by the UCLA Institu-
tional Review Board (IRB). Approval at the other par-
ticipating sites was obtained through a process in which
an institutional IRB agrees to rely upon the review and
approval of another IRB under the auspices of an estab-
lished Memorandum of Understanding. The reliance
procedure enabled the participating medical centers to
avoid site-specific negotiations regarding the consent
documents. The study is registered at ClinicalTrials.gov
(NCT01360203).
Setting and sample
The study is being conducted at six academic medical cen-
ters located throughout the state of California. Five of the
medical centers are part of the University of California
system; the sixth is Cedars-Sinai Medical Center in Los
Angeles, which has a mixed model medical staff that in-
cludes full time faculty, a multi-specialty group practice,
and a large number of independent private physicians.
Three of the health systems are major heart transplant
centers, and three serve as safety net hospitals for their
respective regions. A large proportion of individuals with
heart failure are covered by Medicare, the federal health
insurance program for those who are aged 65 years or
older or disabled, and/or the federal-state Medicaid pro-
gram for the poor. Others may have employer-sponsored
or individual commercial health insurance. All patientssuffering acute exacerbation of heart failure receive in-
patient hospital care in the U.S., regardless of insurance
coverage. However, those who are uninsured may have
difficulty accessing outpatient care.
As an effectiveness study, BEAT-HF seeks to enroll a
broad range of patients hospitalized with heart failure.
Individuals admitted as hospital inpatients or on observa-
tion status are eligible if they are aged 50 years or older, re-
ceiving active treatment for decompensated heart failure
(defined as initiation of or an increase in diuretic treat-
ment), and are expected to be discharged to their home.
According to the U.S. Census Bureau, 43.8% of California
residents aged 5 years and older in 2011 spoke a language
other than English at home [19]. We began study enroll-
ment with patients who spoke the two most common lan-
guages, English or Spanish. Our analysis of patients not
enrolled initially due to language showed that the next
most frequent languages spoken by patients with heart
failure at the six medical centers were Farsi (Persian),
Russian, and Cantonese/Mandarin. We expanded the
study to enroll in both Persian and Russian, but did not
extend to Cantonese/Mandarin or other languages due
to costs of translation and interpreter services. All study
materials, including consent forms, teaching and equip-
ment reference materials, and surveys were translated
to ensure that non-English speaking patients received
the same information. Translation was performed by
professional translators and incorporated appropriate cul-
tural adaptation, as recommended by the IRB overseeing
the study.
The study exclusions can be grouped into three main
categories: (1) patients who do not have the cognitive or
physical ability, or access to resources, required to partici-
pate fully in the BEAT-HF intervention; (2) patients already
in a system of care that provides more health provider con-
tacts than the planned intervention; or (3) patients whose
heart failure is due to a cardiovascular condition that is
expected to improve due to medical intervention. (See
the detailed ‘List of exclusion criteria’).
List of exclusion criteria
1) Lacking ability or resources to participate in
intervention
■ Dementia (3 or more incorrect items of 6 on
Callahan screener)
■ Inability to conduct telephone conversation
despite use of assistive technology
■ No working telephone
■ Inability to stand on scale
■ Weight more than 450 pounds
■ No usual source of care and no provider to be
assigned upon discharge (free clinic is
acceptable)
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or other transitional housing lacking a secure
place to store telemonitoring equipment
2) In a system of care that provides more health
provider contacts than study intervention
■ Long-term residence in skilled nursing facility
■ Expected to be discharged to long-term stay at
skilled nursing facility
■ Expected to be transferred to another acute care
or rehabilitation hospital
■ On chronic hemodialysis
■ Solid organ transplant recipient or listed for
transplant
■ Recipient of left ventricular assist device or
planned to receive one
3) Heart failure is due to a cardiovascular condition
expected to improve with medical intervention
■ Receiving percutaneous coronary intervention
during current stay
■ Interventional valve procedure (surgery or
transcatheter) planned during current admission
4) Other exclusions
■ Admitted with acute myocardial infarction
(except demand ischemia)
■ Critical aortic stenosis (defined as an estimated
valve area of <0.75 cm2) with no intervention
planned
■ Surgery planned during current admission
(cardiovascular or other)
■ On hospice or hospice-bound
■ Residence outside California
■ Currently participating in another
telemonitoring program (for example, through a
health plan or a Veterans Affairs clinic)
Multiple sources are used to screen for patients who po-
tentially meet the study’s inclusion criteria. These include
lists of patients with heart failure prepared by the hospi-
tals’ Core Measures nurses, lists of patients admitted to
cardiology services, pharmacy data on patients receiving
intravenous diuretics, and review of admitting complaints,
for example, shortness of breath, pedal edema. Most ex-
clusions are identified through review of electronic med-
ical records or confirmed with the attending physician or
bedside nurse, prior to approaching patients in person.
Study nurses at each site visit potentially eligible patients
in their hospital rooms to explain the study and determine
interest in participating. Consent is obtained prior to dis-
charge; patients are given time to decide on participation
and many choose to discuss the study with family and
caregivers. All eligible patients are recruited, whenever
possible, however, some are discharged from the hospital
before they can be approached or before completing the
consent process.The six-item Callahan screener is used to evaluate
cognitive ability to participate in the intervention [20]. If
the patient answers three or more questions correctly,
informed consent is obtained and the patient is enrolled.
The study nurse administers the baseline survey and then
randomizes the patient.
Intervention
The BEAT-HF intervention consists of three components:
pre-discharge heart failure education, regularly scheduled
telephone coaching, and home telemonitoring of weight,
blood pressure, heart rate, and symptoms, as illustrated in
Figure 1. The pre-discharge health education is conducted
by the study nurse, who is not part of the usual care team.
The nurse guides patients through a booklet, Caring for
Your Heart: Living Well with Heart Failure, that was
developed for patients with low health literacy [21]. The
topics covered in the booklet include an explanation of
heart failure, medication adherence, salt avoidance, fluid
monitoring, exercising with heart failure, daily check-up
of weight and edema, and when to call the heart failure
treatment team. The study nurse uses the ‘teach-back’
approach to ensure patient understanding. Family mem-
bers or other caregivers are included in the teaching
sessions if they are available and want to participate.
The pre-discharge education also includes a demonstra-
tion of how to use the remote home telemonitoring equip-
ment and an explanation of why monitoring physiologic
parameters is important for patients.
The equipment consists of the FDA-approved Ideal
Life Pod™, a Bluetooth-enabled wireless gateway, the
Ideal Life Body-Manager (weight scale), and the Ideal
Life BP-Manager, a blood pressure/heart rate monitor
integrated with a device that displays text questions and
sends simple text responses. From the user perspective,
these measurement devices are similar to ordinary weight
scales and blood pressure cuffs. The transmission pod is a
simple plug and play device that can be placed anywhere
within a home; it does not need to be in the immediate
vicinity of the measurement devices. We reviewed several
sets of devices from different manufacturers and made the
selection based on ease of use and the company’s willing-
ness to be responsible for all system components. These
devices are similar to those used in previous telehealth
studies [16,22].
The hospital-based nurse provides a ‘warm handoff ’ to
the centralized telephone nurse coaches by giving patients
the name of the nurse who will be contacting them after
discharge and showing her photo. Study nurses use inter-
preters when needed to communicate with patients who
speak Spanish, Persian, or Russian. When interpreters are
not available in person, a three-way telephone interpret-
ation service is used. Patients take the assembled equip-
ment home, along with a binder that includes the heart
Figure 1 Diagram of BEAT-HF patient enrollment, randomization, intervention, and time line.
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study, a toll-free number for technical support by Ideal
Life, a checklist for completion of the 7-day, 30-day,
and 180-day telephone surveys, a copy of the upcoming
7-day survey, and copies of their consent and HIPAA
authorization forms.
A call center nurse first contacts each enrolled patient
2 or 3 days after discharge from the hospital to reinforce
the pre-discharge health coaching topics. Telephone nurse
coaching then occurs on a weekly basis during the first
month post-discharge. The call center nurses have access
to patients’ medical histories and medication records con-
tained in the electronic health records of each participat-
ing medical center. After the first month, nurse coaching
calls are made monthly until the end of the 6-month studyperiod. All intervention patients receive a minimum of
nine scheduled telephone coaching calls, generally from
the same nurse over time.
Intervention patients are asked to use the Ideal Life
Body-Manager and BP-Manager daily to transmit their
weight, blood pressure, heart rate, and responses to three
symptom questions. These wireless devices can be placed
anywhere in a patient’s home. They transmit information
to the Ideal Life Pod, which retransmits the collected data
via the cellular bandwidth to a secure server that is
accessed daily by the centralized call center nurses. There
are two groups of symptom questions that alternate daily,
to reduce respondent burden and minimize repetition.
Readings that exceed predetermined threshold parameters
generate a trigger for the call center nurse, who telephones
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ing, patients are encouraged to contact their providers.
Table 1 shows the biometric parameters and symptom re-
sponses that prompt the nurse to contact the patient’s
physician with an urgent alert. The biometric parameters
can be changed by the physician. If deemed necessary, the
call center nurses will advise patients to call 911 or go to
their nearest hospital emergency room. A call center nurse
also calls any patient who has stopped transmitting data to
determine the reason and encourage the patient to resume
daily monitoring.
Control
After randomization, the site nurse gives patients in the
usual care (control) arm a study binder that contains a
one page summary of the study, a checklist for comple-
tion of the 7-day, 30-day, and 180-day telephone sur-
veys, a copy of the upcoming 7-day survey, and copies of
their consent and HIPAA authorization forms. Control
patients have no further contact with site study nurses
or call center nurses. However, they may be exposed to
other readmission reduction or chronic disease manage-
ment programs implemented by hospitals, physician
groups, or health plans, such as education about heart
failure, pharmacist consultation, and post-discharge tele-
phone calls. We collected information about usual care at
each of the six sites at the beginning of the study and willTable 1 Biometric parameters, symptom questions, and
alert triggers
Biometric parameter Urgent alert
Systolic blood pressure with symptoms SBP < 90 mm Hg
or > 160 mm Hg
Systolic blood pressure without symptoms SBP < 80 mm Hg
or > 170 mm Hg
Heart rate with symptoms HR < 50 or > 100
Heart rate without symptoms HR < 40 or > 110
Weight with symptoms Daily gain > 3 lbs
or weekly gain > 6 lbs
Symptom questions – Group 1
Have you felt more short of breath in the last
day?
Yes
Have you noticed more swelling in the last day? Yes
Have you had any light-headedness or dizziness
in the last day?
Yes
Symptom questions – Group 2
Did you wake up short of breath last night? Yes
Did you sleep in a chair or propped up with
pillows, more than usual last night?
Yes
Compared to yesterday, would you say you are
feeling about the same, better, worse, or much
worse?
Much worse
‘With symptoms’ is determined based on responses to symptom questions, or
ascertained in telephone conversation with the patient.continue to do so during the study, so that we will be able
to describe how the usual care transition for patients with
heart failure has evolved over time.
Study measures
The primary outcome measure is the 180-day all-cause
readmission rate. Secondary outcomes are the 30-day
readmission rate, mortality, ED visits, hospital days,
hospital costs, and HRQOL. These are collected at the
time intervals shown in Table 2. Costs will be analyzed
from both societal and provider perspectives. HRQOL
will be measured by the Minnesota Living with Heart
Failure Questionnaire (MLHFQ) [23]. Table 3 provides
a complete list of variables collected, means of measure-
ment, and timing. The Total Illness Burden Index [24]
will augment co-morbidities obtained from hospital admin-
istrative data. Sociodemographic measures include employ-
ment and productivity questions from the Health and
Work Performance Questionnaire [25]. Other measures
of interest include the brief Care Transition Measure
(CTM-3) [26], the Rapid Estimate of Adult Literacy in
Medicine, Revised (REALM-R) [27], the Geriatric De-
pression Scale [28], heart failure self-care knowledge,
behaviors, and confidence from the Self-Care of Heart
Failure Index (SCHFI) [29], the Lubben Social Network
Scale [30], questions about informal caregiving [31], and
the Morisky Medication Adherence Scale [32]. In addition
to the adherence measures included in the survey ques-
tionnaire, we will measure adherence to the overall inter-
vention and its components using data transmission
records and telephone call documentation. The final (180-
day) survey also includes questions about satisfaction with
the overall intervention, the post-discharge nurse compo-
nent, and the post-discharge device component.
Data collection
Same-hospital readmissions and hospital days will be
obtained from administrative data routinely submitted
by the study hospitals to the University HealthSystem
Consortium (UHC), a voluntary association of academic
medical centers to which all six participating medical
centers belong. ED visits to the study hospitals as well
as readmissions, hospital days, and ED visits to other
California hospitals will be obtained through linked in-
patient discharge and ED data from the California Office
of Statewide Health Planning and Development (OSHPD),
submission of which is mandated by state law. Hospital
costs for the study hospitals will be obtained from the
UHC data, while costs for admissions and ED visits to
non-study hospitals will be estimated from the OSHPD
data.
A baseline survey is conducted face-to-face by the hos-
pital study nurse prior to randomization. Patient reported
data are collected by telephone surveys conducted at
Table 2 Outcome measures
Time frame Readmission rate Mortality Emergency department
(ED) visits




Inpatient death Index length of
stay
Total hospital costs MLHFQ
score
























MLHFQ is Minnesota Living with Heart Failure Questionnaire.
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pital discharge. The telephone survey interviewers are
blinded to the respondent’s randomization status. Study
patients are given a paper copy of the 7-day survey as part
of their enrollment packet and receive advance copies of
each upcoming survey by mail. They receive a $10 gift
card in the mail following completion of each telephone
survey.
A Data and Safety Monitoring Board (DSMB) is over-
seeing the conduct of the study. The committee consists
of three researchers from universities not involved in the
study. Two members of the UCLA Department of Medi-
cine who are not involved in the study convey data from
the study team to the DSMB. Adverse event reports are
completed for patient readmissions and deaths and
reviewed by the DSMB, with the primary objective of as-
certaining any delays in care that occur because patients
rely on being monitored by the study.
Statistical analysis
Our analytic approach will use multivariate regression
analysis to compare study outcomes between the interven-
tion and usual care groups, adjusting for patient character-
istics that can influence resource use and mortality. These
analyses will use an intent-to-treat (ITT) framework,
within a hierarchical approach using information on med-
ical centers and patients.
Confounding will be assessed by comparing the un-
adjusted coefficient for treatment condition with the ad-
justed coefficient. Several of the resource use variables,
such as trigger calls and total 180-day hospital readmis-
sions, will likely have non-normal distributions with high
skew. As in previous analyses [6], we will draw upon
statistical approaches and models developed for handling
this type of data, such as transformation for non-normal
distributions; two-part models to handle zero values and
skewed non-zero values separately; split-sample techniques
to distinguish between different functional forms and to
avoid overfitting; and count models (for example, Poisson
and negative binomial models). We will confirm model
selection with goodness of fit tests. Although BEAT-HF is
not a cluster randomized trial, there is potentially non-
random clustering of patient characteristics occurring atthe six study sites because we randomized within hospi-
tals. As a result, our quantitative analyses will use mixed
effects hierarchical linear models, with two-level models
for analyses of patients nested within medical centers, and
three-level models for analyses of repeated measurements
on patients nested within medical centers.
Sample size
Sample size was calculated based on the assumption that
the control group would experience no change in the
observed baseline 180-day readmission rate of 38%. A
sample size of 1,500 (750 per arm) will provide 80%
power to detect a relative reduction of 28% in the primary
outcome with a significance level of 0.05, after adjusting
for within-hospital clustering. We expect to screen ap-
proximately 31,500 admissions in order to enroll 1,500
patients. Patients who are readmitted after having given
a firm refusal are not asked again, but those with a ‘soft’
refusal are approached again if readmitted.
Discussion
The BEAT-HF approach differs from telemonitoring pro-
grams previously described in several ways. It incorporates
elements of successful care transition programs by en-
gaging patients during their hospitalization and combining
centralized structured telephone support with telemoni-
toring. Tele-HF was classified as a structured telephone
support intervention, because it used an interactive voice
response system that requires patients to enter informa-
tion such as weight and blood pressure on a standard
telephone keypad, but the ‘interaction’ was between the
patient and a recorded voice. In BEAT-HF, the tele-
phone is used for a coaching interaction between pa-
tient and nurse. In Tele-HF, monitoring data were sent
directly to a cardiologist affiliated with the recruitment
site, not the patient’s regular physician. The BEAT-HF
nurses first call the patient in response to an alert trig-
ger, enabling them to screen out false readings and to
assess the severity of the patient’s symptoms. They also
interact by telephone with patients’ regular providers,
communicating the trigger in its clinical context and re-
inforcing existing patient-provider relationships by provid-
ing additional information about their patients’ needs.
Table 3 Source and schedule of outcome, utilization, process, and other variables
Post-discharge
Variable Source/Instrument Baseline 7-days 30-days 180-days
Outcomes
Readmission UHC, OSHPD X X X
Hospital days UHC, OSHPD X X X
Hospital cost UHC, OSHPD
Emergency Dept use OSHPD X X X
Mortality UHC, OSHPD, National Death Index X X X
Quality of life Survey/Minnesota Living with Heart
Failure Questionnaire
X X X X
Intervention process
Pre-discharge education completion and comprehension Enrollment documentation notes X
Post-discharge health coaching Call center documentation notes * * *
Remote monitor use Daily data transmission reports * * *
Calls triggered by remote monitoring Data transmission reports, call center
documentation notes
* * *
Patient assessment of care transition Survey/Care Transition Measure-3 X
Covariates
Age Survey, UHC X
Gender Survey, UHC X
Race/Ethnicity Survey, UHC X
Language Survey, language of consent X
Household income Survey X
Education Survey X
Marital status Survey X
Insurance (for example, dual Medicaid/Medicare) UHC X
Employment Survey/Health and Work Performance
Questionnaire
X X X
Health literacy Survey/REALM-R X
Severity of illness Survey/Total Illness Burden Index X X
Co-morbidities UHC X
Depression Survey/Geriatric Depression Scale X X X X
Self-care behaviors Survey/Self-Care of Heart Failure Index X X X X
Social networks Survey/Lubben Social Network Scale X X X
Informal caregiving Survey/Medical Care Questionnaire X X X
Medication adherence Survey/Morisky Medication Adherence Scale X X X
End-of-life wishes Survey X
*Signifies the measure is continuously available over the 180-day timeframe.
UHC is University HealthSystem Consortium; OSHPD is Office of Statewide Health Planning & Development.
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the nurses to support significantly more patients than if
they were traveling to patients’ homes. Centralizing the
nurses enables them to serve patients discharged from
multiple hospitals, including those where the volume of
heart failure patients would not be sufficient to employ a
full-time nurse efficiently. The issue of scale is important
because the prevalence of patients with heart failure maybe too great to accommodate them in comprehensive dis-
ease management programs that rely on specialized clinics
or home visits. In addition, some patients are too frail to
make regular visits to outpatient clinics [33,34]. The initial
follow-up for monitoring triggers is performed centrally,
assuring a uniform response. Finally, combining nurse
coaching with telemonitoring allows the nurse to address
issues related to patient use of the equipment.
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elucidate some of the reasons for non-adherence, a
problem experienced by Tele-HF and other studies.
These reasons may include real or perceived equipment
failure or lack of reliability, patients who travel, patients
who are admitted to skilled nursing or readmitted to a
hospital, as well as behavioral non-adherence. This in-
formation will be extracted from the call logs main-
tained by the call center nurses and Ideal Life service
representatives. Some of the technical difficulties may
be due to human factors issues.
It is likely there will be variation in the ‘dose’ of inter-
vention received by patients over the 180 days of the study
in terms of both their adherence to telemonitoring and
acceptance of coaching telephone calls. The primary out-
come will be analyzed on an intention-to-treat basis. How-
ever, it also will be important to evaluate whether there is
a dose-response effect. The ‘dose’ of telemonitoring will be
captured automatically by the data transmissions. The
dose of nurse coaching is affected not only by patients’
willingness to accept calls, but by the number of alert trig-
gers generated by the patients’ transmitted parameters.
The quantity of triggers may be associated with a patient’s
severity of illness, but it may also reflect persistently high
or low blood pressure or heart rate, or technical difficulties
with the equipment.
The BEAT-HF study has other strengths. It is larger
than most care transition or telehealth studies for heart
failure, and may be the only large U.S. study to include a
substantial proportion of patients with limited or no
English proficiency. The patients are treated in different
systems of care, with medical centers ranging from a
safety net provider for a large, mixed urban-rural area to a
major urban hospital that incorporates elements of both
academic medicine and a large private practice medical
staff.
At the same time, the study faces several challenges.
The ascertainment of patient readmissions and ED visits
is key. Because approximately 20% of readmissions occur
to other (non-study) hospitals, and patients may not re-
member hospitalizations or ED visits, complete determin-
ation of utilization will depend on the success of matching
patient identification data with OSHPD data.
Rapidly changing telecommunications technology led
to technical problems at the beginning of the study. The
Ideal Life equipment deployed initially used a modem
that required landline telephone service to transmit
data. However, a growing number of households no lon-
ger have traditional telephone service because they use
a subscription or prepaid mobile phone exclusively, or
they have bundled television, internet, and telephone
service which disrupted landline data transmission. In
response, Ideal Life introduced the Pod™, which uses
any available cellular signal. Technology issues have ledboth research staff and Ideal Life representatives to
dedicate more time than planned to individual patient
trouble-shooting and home visits and increased the
number of contacts between the call center nurses and
some patients.
This study is taking place during a time of significant
change in hospitals’ financial and regulatory environment.
Reducing readmissions plays a key role in each of the top
three priorities identified by hospital CEOs responding to
an annual survey conducted by the American College of
Healthcare Executives: financial concerns, patient safety
and quality, and implementing health reform [35]. To
the extent possible, it will be important to identify other
disease management initiatives underway at the partici-
pating sites and to assess their effect on both control
and intervention patients [36]. We recognize that other
initiatives may create an environment that is particu-
larly responsive - or unresponsive - to telemonitoring
and patient education.
Despite our best efforts to recruit a sample that is repre-
sentative of the target population of older adults with
heart failure, our results may have limited generalizability.
In particular, our sample will inevitably under-represent
some of the highest risk, most vulnerable patients in our
communities: those housed long-term in skilled nursing
facilities, those without a usual source of medical care,
those without insurance or with limited Medicaid cover-
age, those who require chronic renal dialysis, those with
moderate-to-severe cognitive impairment, those who are
too functionally impaired to use a scale and a telephone,
and immigrants who speak only Asian or other languages
not used in the study. However, it may be inevitable that
system interventions, such as those studied in BEAT-HF,
can only be delivered in certain settings, and must be
adapted before they can be delivered in other settings or
to other populations.
BEAT-HF is one of the largest randomized controlled
trials of a telehealth approach to improving outcomes
for patients with heart failure. It incorporates elements
of successful care transition programs, combining cen-
tralized structured telephone support provided by nurses
with home telemonitoring using the latest remote moni-
toring technology. BEAT-HF is enrolling patients with a
wide range of socioeconomic and demographic back-
grounds and collecting extensive data on intermediate
factors that potentially affect patient adherence. As a
result, the study will provide a wealth of information on
how different individuals use technology and respond to
interventions that are not face-to-face encounters. Once
completed, BEAT-HF is poised to serve as an important
research resource to understand how best to use tele-
health approaches to improve key healthcare processes
and outcomes, including care transitions and hospital
readmissions, and to set the stage for future comparative
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heart failure.
Trial status
At the time of manuscript submission, the BEAT-HF
study is actively enrolling participants.
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